SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,027,000 | +208.4% | 30,800 | +167.8% | 0.03% | +166.7% |
| Q2 2020 | $1,954,000 | +283.1% | 11,500 | +160.2% | 0.01% | +200.0% |
| Q1 2020 | $510,000 | -93.6% | 4,419 | -93.6% | 0.00% | -92.7% |
| Q4 2019 | $7,938,000 | +114.4% | 69,463 | +60.2% | 0.06% | +71.9% |
| Q3 2019 | $3,702,000 | +118.4% | 43,356 | +77.0% | 0.03% | +128.6% |
| Q2 2019 | $1,695,000 | -56.6% | 24,500 | -54.0% | 0.01% | -53.3% |
| Q1 2019 | $3,904,000 | +45.1% | 53,300 | +12.3% | 0.03% | +57.9% |
| Q4 2018 | $2,690,000 | +226.1% | 47,480 | +343.7% | 0.02% | +280.0% |
| Q3 2018 | $825,000 | -62.5% | 10,700 | -67.7% | 0.01% | -54.5% |
| Q2 2018 | $2,198,000 | -70.0% | 33,100 | -76.4% | 0.01% | -73.8% |
| Q1 2018 | $7,333,000 | +912.8% | 140,089 | +953.3% | 0.04% | +950.0% |
| Q3 2017 | $724,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |